Advertisement
Research Article| Volume 147, ISSUE 1, P41-45, November 2009

Serum relaxin levels are reduced in pregnant women with a history of recurrent miscarriage, and correlate with maternal uterine artery Doppler indices in first trimester

  • Dilly O.C. Anumba
    Correspondence
    Corresponding author. Tel.: +44 114 226 1075; fax: +44 114 226 8538.
    Affiliations
    Section of Endocrinology and Reproduction, Academic Unit of Reproductive and Developmental Medicine, The University of Sheffield, 4th Floor, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, UK
    Search for articles by this author
  • Saad El Gelany
    Affiliations
    Section of Endocrinology and Reproduction, Academic Unit of Reproductive and Developmental Medicine, The University of Sheffield, 4th Floor, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, UK
    Search for articles by this author
  • Sarah L. Elliott
    Affiliations
    Section of Endocrinology and Reproduction, Academic Unit of Reproductive and Developmental Medicine, The University of Sheffield, 4th Floor, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, UK
    Search for articles by this author
  • Tin C. Li
    Affiliations
    Section of Endocrinology and Reproduction, Academic Unit of Reproductive and Developmental Medicine, The University of Sheffield, 4th Floor, Jessop Wing, Tree Root Walk, Sheffield S10 2SF, UK
    Search for articles by this author

      Abstract

      Objectives

      Defective implantation is a mechanism for recurrent pregnancy loss (RPL). We sought to determine whether the serum expression of human relaxin-2 (RLX) is impaired in women with a history of RPL.

      Study design

      Employing a prospective case-controlled design we studied 20 pregnant women with a history of RPL and 20 age-matched women with no history of RPL (NRPL). We measured serum relaxin-2 levels by ELISA at 6–8, 10–12, 20, and 34 weeks gestation and in cord blood, and maternal uterine artery Doppler resistance index (RI) at ≥10 weeks gestation.

      Results

      Relaxin rose to a peak at 12 weeks, and gradually declined towards term. At all gestations, women with a history of RPL had lower RLX levels than women without. At 10–12 weeks gestation, uterine artery RI correlated with serum RLX for both RPL and NRPL. In the NRPL group at 10–12 weeks the presence of a notched waveform was associated with higher RLX levels than the absence of a notch (mean 2.1 ng/ml vs. 1.3 ng/ml, P < 0.05) and also at 20 weeks (2.1 ng/ml vs. 0.95 ng/ml, P < 0.05) but no such difference was seen in the RPL group. Umbilical venous RLX was 4-fold higher in the RPL group than the NRPL group.

      Conclusion

      Women with a history of RPL demonstrate attenuated levels of serum RLX across all pregnancy trimesters. How dysregulated RLX metabolism may contribute to adverse pregnancy outcome in RPL requires further investigation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Mtiraoui N.
        • Borgi L.
        • Gris J.C.
        • Almawi W.Y.
        • Mahjoub T.
        Factor V Leiden, prothrombin G20210A and antibodies against phospholipids in recurrent spontaneous abortion.
        J Thromb Haemost. 2004; 2: 1482-1484
        • Emmer P.M.
        • Steegers E.A.
        • Kerstens H.M.
        • et al.
        Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies.
        Hum Reprod. 2002; 17: 1072-1080
        • Palomba S.
        • Falbo A.
        • Orio Jr., F.
        • Russo T.
        • Tolino A.
        • Zullo F.
        Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome.
        Fertil Steril. 2006; 85: e3-e5
        • Craig L.B.
        • Ke R.W.
        • Kutteh W.H.
        Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss.
        Fertil Steril. 2002; 78: 487-490
        • Jivraj S.
        • Anstie B.
        • Cheong Y.C.
        • Fairlie F.M.
        • Laird S.M.
        • Li T.C.
        Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study.
        Hum Reprod. 2001; 16: 102-106
        • Nicolaides K.H.
        • Bindra R.
        • Turan O.M.
        • et al.
        A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.
        Ultrasound Obstet Gynecol. 2006; 27: 13-17
        • Prakash A.
        • Laird S.
        • Tuckerman E.
        • Li T.C.
        • Ledger W.L.
        Inhibin A and activin A may be used to predict pregnancy outcome in women with recurrent miscarriage.
        Fertil Steril. 2005; 83: 1758-1763
        • Salim R.
        • Miel J.
        • Savvas M.
        • Lee C.
        • Jurkovic D.
        A comparative study of glycodelin concentrations in uterine flushings in women with subseptate uteri, history of unexplained recurrent miscarriage and healthy controls.
        Eur J Obstet Gynecol Reprod Biol. 2007; 133: 76-80
        • Carp H.
        • Dardik R.
        • Lubetsky A.
        • et al.
        Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study.
        Hum Reprod. 2004; 19: 191-195
        • Laird S.M.
        • Quinton N.D.
        • Anstie B.
        • Li T.C.
        • Blakemore A.I.
        Leptin and leptin-binding activity in women with recurrent miscarriage: correlation with pregnancy outcome.
        Hum Reprod. 2001; 16: 2008-2013
        • Johnson M.R.
        • Jauniaux E.
        • Jurkovic D.
        • Sannino P.
        • Campbell S.
        • Nicolaides K.H.
        Relaxin concentrations in exoembryonic fluids during the first trimester.
        Hum Reprod. 1994; 9: 1561-1562
        • Piccinni M.P.
        • Maggi E.
        • Romagnani S.
        Role of hormone-controlled T-cell cytokines in the maintenance of pregnancy.
        Biochem Soc Trans. 2000; 28: 212-215
        • Bogic L.V.
        • Yamamoto S.Y.
        • Millar L.K.
        • Bryant-Greenwood G.D.
        Developmental regulation of the human relaxin genes in the decidua and placenta: overexpression in the preterm premature rupture of the fetal membranes.
        Biol Reprod. 1997; 57: 908-920
        • Parry L.J.
        • Vodstrcil L.A.
        Relaxin physiology in the female reproductive tract during pregnancy.
        Adv Exp Med Biol. 2007; 612: 34-48
        • Petersen L.K.
        • Vogel I.
        • Agger A.O.
        • Westergard J.
        • Nils M.
        • Uldbjerg N.
        Variations in serum relaxin (hRLX-2) concentrations during human pregnancy.
        Acta Obstet Gynecol Scand. 1995; 74: 251-256
        • Hollis B.
        • Mavrides E.
        • Campbell S.
        • Tekay A.
        • Thilaganathan B.
        Reproducibility and repeatability of transabdominal uterine artery Doppler velocimetry between 10 and 14 weeks of gestation.
        Ultrasound Obstet Gynecol. 2001; 18: 593-597
        • Seki K.
        • Uesato T.
        • Tabei T.
        • Kato K.
        Serum relaxin and steroid hormones in spontaneous abortions.
        Acta Obstet Gynecol Scand. 1988; 67: 483-486
        • Gardosi J.
        • Mongelli M.
        • Wilcox M.
        • Chang A.
        An adjustable fetal weight standard.
        Ultrasound Obstet Gynecol. 1995; 6: 168-174
        • Jauniaux E.
        • Johnson M.R.
        • Jurkovic D.
        • Ramsay B.
        • Campbell S.
        • Meuris S.
        The role of relaxin in the development of the uteroplacental circulation in early pregnancy.
        Obstet Gynecol. 1994; 84: 338-342
        • Maynard S.E.
        • Min J.Y.
        • Merchan J.
        • et al.
        Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
        J Clin Invest. 2003; 111: 649-658
        • Unemori E.N.
        • Erikson M.E.
        • Rocco S.E.
        • et al.
        Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women.
        Hum Reprod. 1999; 14: 800-806
        • Johnson M.R.
        • Abdalla H.
        • Allman A.C.
        • Wren M.E.
        • Kirkland A.
        • Lightman S.L.
        Relaxin levels in ovum donation pregnancies.
        Fertil Steril. 1991; 56: 59-61
        • Bogic L.V.
        • Mandel M.
        • Bryant-Greenwood G.D.
        Relaxin gene expression in human reproductive tissues by in situ hybridization.
        J Clin Endocrinol Metab. 1995; 80: 130-137
        • Goldsmith L.T.
        • Weiss G.
        • Steinetz B.G.
        Relaxin and its role in pregnancy.
        Endocrinol Metab Clin North Am. 1995; 24: 171-186
        • MacLennan A.H.
        • Grant P.
        • Borthwick A.C.
        Relaxin and relaxin c-peptide levels in human reproductive tissues.
        Reprod Fertil Dev. 1991; 3: 577-583
        • Sakbun V.
        • Ali S.M.
        • Greenwood F.C.
        • Bryant-Greenwood G.D.
        Human relaxin in the amnion, chorion, decidua parietalis, basal plate, and placental trophoblast by immunocytochemistry and northern analysis.
        J Clin Endocrinol Metab. 1990; 70: 508-514
        • Yki-Jarvinen H.
        • Wahlstrom T.
        • Seppala M.
        Immunohistochemical demonstration of relaxin in the genital tract of pregnant and nonpregnant women.
        J Clin Endocrinol Metab. 1983; 57: 451-454